Integrated Subcutaneous Monitoring and Delivery System

A novel system combining subcutaneous monitoring devices with advanced technologies like AI, IoT, blockchain, and nanomaterials to provide real-time personalized health recommendations and targeted therapeutic delivery.

The original subcutaneous delivery tool patent addressed the need for efficient implantation of medical devices. However, it lacked the capability to monitor physical parameters, provide real-time feedback, and integrate with emerging technologies. The new inventive concept solves this problem by creating a comprehensive system that integrates subcutaneous monitoring, data analysis, and targeted delivery.

The system consists of a subcutaneous monitoring device, a blockchain-based data storage unit, and a machine learning algorithm for analyzing the monitored data and generating personalized health recommendations. The system can be integrated with IoT-enabled wearable devices, cloud-based data analytics platforms, and nanomaterial-based coatings for enhanced biocompatibility. The micro-needle array is configured to deliver therapeutic agents to target sites, and the sensor detects the subcutaneous environment. The wearable device features a flexible, stretchable material-based sensor array, a power harvesting unit, and a wireless communication module.

The new claims introduce the integration of subcutaneous monitoring devices with AI, IoT, blockchain, and nanomaterials, which is not obvious from the original patent. The combination of these technologies enables real-time personalized health recommendations and targeted therapeutic delivery, providing a novel and non-obvious solution.

Alternative embodiments could include the use of different AI algorithms, varying IoT connectivity protocols, or alternative nanomaterials for enhanced biocompatibility. The system could also be adapted for use in various medical applications, such as diabetes management or cardiovascular monitoring.

The integrated subcutaneous monitoring and delivery system has significant commercial potential in the healthcare industry, particularly in the fields of personalized medicine, remote patient monitoring, and targeted therapeutic delivery. The system could be marketed to hospitals, clinics, and medical research institutions, and could also be used in consumer-facing applications, such as wearable devices for health and wellness monitoring.